SRDX Surmodics PE ratio, current and historical analysis
The current PE ratio of SRDX can't be determined, as the TTM EPS of -$1.02 is negative. The most recent PE ratio recorded for Surmodics was 30.56 in March 2024.
SRDX PE ratio history
Over the last ten years, the average PE ratio of Surmodics has been 169.76. Over the past ten years, SRDX's PE ratio was at its highest in the Dec 2020 quarter at 870.4, with a price of $43.52 and an EPS of $0.05. The Sep 2015 quarter recorded the bottom point at 23.74, with a price of $21.84 and an EPS of $0.92.
Surmodics PE ratio by year
Maximum annual increase: 506.08% in 2020
Maximum annual decrease: -63.13% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $38.78 | -$0.82 |
| 2023 | N/A | N/A | $32.09 | -$0.11 |
| 2022 | N/A | N/A | $30.4 | -$1.96 |
| 2021 | 179.35 | -63.13% | $55.6 | $0.31 |
| 2020 | 486.38 | 506.08% | $38.91 | $0.08 |
| 2019 | 80.25 | N/A | $45.74 | $0.57 |
| 2018 | N/A | N/A | $74.65 | -$0.34 |
| 2017 | 103.33 | 164.41% | $31 | $0.3 |
| 2016 | 39.08 | 64.62% | $30.09 | $0.77 |
| 2015 | 23.74 | 15.02% | $21.84 | $0.92 |
| 2014 | 20.64 | -8.87% | $18.16 | $0.88 |
| 2013 | 22.65 | -33.91% | $23.78 | $1.05 |
| 2012 | 34.27 | N/A | $20.22 | $0.59 |
| 2011 | N/A | N/A | $9.1 | -$1.06 |
| 2010 | N/A | N/A | $11.92 | -$1.21 |
Surmodics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $39.6 | -$1.02 |
| Sep 2024 | N/A | N/A | $38.78 | -$0.82 |
| Jun 2024 | N/A | N/A | $42.04 | -$0.09 |
| Mar 2024 | 30.56 | -67.21% | $29.34 | $0.96 |
| Dec 2023 | 93.21 | N/A | $36.35 | $0.39 |
| Sep 2023 | N/A | N/A | $32.09 | -$0.11 |
| Jun 2023 | N/A | N/A | $31.31 | -$1.65 |
| Mar 2023 | N/A | N/A | $22.78 | -$2.58 |
| Dec 2022 | N/A | N/A | $34.12 | -$2.32 |
| Sep 2022 | N/A | N/A | $30.4 | -$1.96 |
| Jun 2022 | N/A | N/A | $37.23 | -$0.92 |
| Mar 2022 | N/A | N/A | $45.33 | -$0.75 |
| Dec 2021 | 370.38 | 106.51% | $48.15 | $0.13 |
| Sep 2021 | 179.35 | -63.63% | $55.6 | $0.31 |
| Jun 2021 | 493.18 | 366.19% | $54.25 | $0.11 |
SRDX average PE ratio chart
SRDX PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| ALKS Alkermes plc | 14.23 | $5.14B |
| ABT Abbott Laboratories | 17.25 | $229.52B |
| A Agilent Technologies Inc | 25.25 | $31.46B |
| JNJ Johnson & Johnson | 27.41 | $385.34B |
| TMO Thermo Fisher Scientific Inc | 28.56 | $178.64B |
| NKTR Nektar Therapeutics | N/A | $110.28M |
| ENZ Enzo Biochem Inc | N/A | $16.98M |
| HRTX Heron Therapeutics Inc | N/A | $327.51M |
| SRDX Surmodics Inc | N/A | $430.31M |
Frequently asked questions
What is Surmodics's PE ratio?
The current price to earnings ratio of SRDX can't be calculated, as its EPS of -$1.02 is negative.
What is the 5-year average PE ratio for Surmodics (SRDX)?
The 5-year average PE ratio for SRDX stock is 300.57.
What is the highest PE ratio for SRDX?
Over the last ten years, the quarterly PE ratio reached a historic high of 870.4 in the Dec 2020 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.